The Government of Australia has announced funding for three medical breakthroughs to aid patients with severe disabilities and chronic back pain in the country.

From the A$500m ($402.6m) Biomedical Translation Fund (BTF) of the National Innovation and Science Agenda, a total of A$13.3m ($10.6m) will be invested towards the new medical initiatives.

Rex Bionics will receive A$5m ($4m) of the total funding to develop a hands-free robotic device for people with the severe inability to walk, exercise and rehabilitate.

The government intends to invest A$3.3m ($2.6m) in Saluda Medical for neuromodulation technology to assist people with debilitating conditions such as chronic back pain.

CHARM Informatics will be provided with A$5m ($4m) for data aggregation and commercialisation services for smart medical device developers.

"This vital funding will support researchers when they need it most."

According to Australian health minister Greg Hunt, BTF acts as a vital funding bridge between the lab and patient to ensure the continuation of biomedical research during translation to market phase.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Hunt said: “This vital funding will support researchers when they need it most – for clinical testing, developing prototypes and other requirements before a high-potential product or service can come on the market.

“These new BTF investments reflect the government’s commitment to deliver the benefits of health and medical research to Australian patients.”

Australia Industry, Innovation and Science minister Arthur Sinodinos said that in addition to enhancing biomedical research, BTF helps in creating jobs across the health and medical research sector.

Sinodinos further added: “As well as the BTF, the Turnbull Government is supporting innovation and growth in the sector through the A$20bn ($16bn) Medical Research Future Fund and the research and development tax incentive.”